0001209191-16-139572.txt : 20160901
0001209191-16-139572.hdr.sgml : 20160901
20160901200049
ACCESSION NUMBER: 0001209191-16-139572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160830
FILED AS OF DATE: 20160901
DATE AS OF CHANGE: 20160901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYANT DOUGLAS C
CENTRAL INDEX KEY: 0001406652
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 161866852
MAIL ADDRESS:
STREET 1: C/O QUIDEL CORPORATION
STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-30
0
0000353569
QUIDEL CORP /DE/
QDEL
0001406652
BRYANT DOUGLAS C
12544 HIGH BLUFF DRIVE, SUITE 200
SAN DIEGO
CA
92130
1
1
0
0
President & CEO
Common Stock
2016-08-30
4
M
0
2832
8.50
A
276843
D
Common Stock
2016-08-30
4
S
0
2832
22.00
D
274011
D
Non-Qualified Stock Options
8.50
2016-08-30
4
M
0
2832
0.00
D
2013-04-10
2019-04-10
Common Stock
2832
202380
D
All of the transactions reported in this Form 4 were effected pursuant to a pre-established 10b5-1 trading plan.
Robert J. Bujarski, attorney-in-fact for Douglas C. Bryant
2016-09-01